Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy
- PMID: 11264432
- DOI: 10.1203/00006450-200104000-00010
Cerebral glucose metabolism measured by positron emission tomography in term newborn infants with hypoxic ischemic encephalopathy
Abstract
Total and regional cerebral glucose metabolism (CMRgl) was measured by positron emission tomography with 2-((18)F) fluoro-2-deoxy-D-glucose ((18)FDG) in 20 term infants with hypoxic ischemic encephalopathy (HIE) after perinatal asphyxia. All infants had signs of perinatal distress, and 15 were severely acidotic at birth. Six infants developed mild HIE, twelve moderate HIE, and two severe HIE during their first days of life. The positron emission tomographic scans were performed at 4-24 d of age (median, 11 d). One hour before scanning, 2-3.7 MBq/kg (54-100 microCi/kg) (18)FDG was injected i.v. No sedation was used. Quantification of CMRgl was based on a new method employing the glucose metabolism of the erythrocytes, requiring only one blood sample. In all infants, the most metabolically active brain areas were the deep subcortical parts, thalamus, basal ganglia, and sensorimotor cortex. Frontal, temporal, and parietal cortex were less metabolically active in all infants. Total CMRgl was inversely correlated with the severity of HIE (p < 0.01). Six infants with mild HIE had a mean (range) CMRgl of 55.5 (37.7-100.8) micromol.min(-1).100 g(-1), 11 with moderate HIE had 26.6 (13.0-65.1) micromol.min(-1).100 g(-1), and two with severe HIE had 10.4 and 15.0 micromol.min(-1).100 g(-1), respectively. Five of six infants who developed cerebral palsy had a mean (range) CMRgl of 18.1 (10.2-31.4) micromol.min(-1).100 g(-1) compared with 41.5 (13.0-100.8) micromol.min(-1).100 g(-1) in the infants with no neurologic sequela at 2 y. We conclude that CMRgl measured during the subacute period after perinatal asphyxia in term infants is highly correlated with the severity of HIE and short-term outcome.
Similar articles
-
Cerebral glucose metabolism and early EEG/aEEG in term newborn infants with hypoxic-ischemic encephalopathy.Pediatr Res. 2003 Dec;54(6):854-60. doi: 10.1203/01.PDR.0000088068.82225.96. Epub 2003 Aug 20. Pediatr Res. 2003. PMID: 12930918
-
Reduced postnatal cerebral glucose metabolism measured by PET after asphyxia in near term fetal lambs.J Neurosci Res. 2001 Dec 1;66(5):844-50. doi: 10.1002/jnr.10051. J Neurosci Res. 2001. PMID: 11746410
-
Changes of positron emission tomography in newborn infants at different gestational ages, and neonatal hypoxic-ischemic encephalopathy.Pediatr Neurol. 2012 Feb;46(2):116-23. doi: 10.1016/j.pediatrneurol.2011.11.005. Pediatr Neurol. 2012. PMID: 22264707
-
Fifty years of brain imaging in neonatal encephalopathy following perinatal asphyxia.Pediatr Res. 2017 Jan;81(1-2):150-155. doi: 10.1038/pr.2016.195. Epub 2016 Sep 27. Pediatr Res. 2017. PMID: 27673422 Review.
-
Imaging Brain Metabolism in the Newborn.J Child Neurol. 2018 Nov;33(13):851-860. doi: 10.1177/0883073818792308. Epub 2018 Aug 16. J Child Neurol. 2018. PMID: 30112963 Review.
Cited by
-
Assessing the early changes of cerebral glucose metabolism via dynamic (18)FDG-PET/CT during cardiac arrest.Metab Brain Dis. 2015 Aug;30(4):969-77. doi: 10.1007/s11011-015-9658-0. Epub 2015 Feb 24. Metab Brain Dis. 2015. PMID: 25703241
-
The effect of sulforaphane on perinatal hypoxic-ischemic brain injury in rats.Physiol Res. 2022 Jul 29;71(3):401-411. doi: 10.33549/physiolres.934878. Epub 2022 May 26. Physiol Res. 2022. PMID: 35616041 Free PMC article.
-
The expression and clinical value of ubiquitin carboxyl-terminal hydrolase L1 in the blood of neonates with hypoxic ischemic encephalopathy.Transl Pediatr. 2021 Aug;10(8):2063-2068. doi: 10.21037/tp-21-327. Transl Pediatr. 2021. PMID: 34584876 Free PMC article.
-
Dynamic FDG PET for assessing early effects of cerebral hypoxia and resuscitation in new-born pigs.Eur J Nucl Med Mol Imaging. 2012 May;39(5):792-9. doi: 10.1007/s00259-011-2055-y. Eur J Nucl Med Mol Imaging. 2012. PMID: 22297457
-
Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.Stem Cell Res Ther. 2020 Feb 3;11(1):43. doi: 10.1186/s13287-019-1545-x. Stem Cell Res Ther. 2020. PMID: 32014055 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous